Ceribell, Inc.
For the period ended Sep 30, 2025. Filed Nov 4, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 4, 2025
CBLL$27.48-0.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Statements of Cash Flows
(in thousands)
| Nine months ended September 30, | ||
|---|---|---|
| 2025 | 2024 | |
| Cash flows from operating activities | ||
| Net loss | $(39,885) | $(27,879) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation and amortization expense | 1,050 | 777 |
| Non-cash lease expense | (76) | 51 |
| Stock-based compensation expense | 8,864 | 3,209 |
| Amortization of debt discount and accretion of premium on term loans | 308 | 289 |
| Accretion (amortization) of discount and premium on marketable securities | (1,389) | — |
| Change in fair value of warrant liability | — | 417 |
| Loss on disposal of property and equipment and recorders | 79 | 82 |
| Changes in operating assets and liabilities: | ||
| Accounts receivable, net | (1,356) | (2,018) |
| Inventory | 913 | (1,041) |
| Prepaid expenses and other current assets | 391 | (137) |
| Contract costs | (627) | (298) |
| Other non-current assets | (221) | (65) |
| Accounts payable | 1,156 | 1,153 |
| Accrued liabilities and other current liabilities | 748 | 504 |
| Contract liabilities | 11 | (112) |
| Net cash used in operating activities | (30,034) | (25,068) |
| Cash flows from investing activities | ||
| Purchases of recorders and related components | (382) | (122) |
| Purchases of property and equipment | (588) | (983) |
| Purchases of marketable securities | (188,775) | — |
| Proceeds from maturities of marketable securities | 45,500 | — |
| Net cash used in investing activities | (144,245) | (1,105) |
| Cash flows from financing activities | ||
| Proceeds related to employee stock plans | 3,798 | 940 |
| Proceeds from debt issuance | — | 7,905 |
| Debt issuance cost | (150) | (304) |
| Payment of deferred IPO offering costs | — | (2,753) |
| Net cash provided by financing activities | 3,648 | 5,788 |
| Net decrease in cash and cash equivalents | (170,631) | (20,385) |
| Cash and cash equivalents, beginning of period | 194,370 | 34,495 |
| Cash and cash equivalents, end of period | $23,739 | $14,110 |
| Supplemental disclosure of cash flow information | ||
| Cash paid for interest | $1,430 | $1,194 |
| Right-of-use asset obtained in exchange for operating lease obligation | — | 778 |
| Property and equipment included in accounts payable and accrued liabilities | 27 | 178 |
| Recorder components included in accounts payable and accrued liabilities | 40 | 61 |
| Unpaid deferred IPO offering costs included in accounts payable and accrued liabilities | — | 1,142 |
Ceribell, Inc.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.